Latest On Neurocrine Biosciences, Inc (NBIX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-01-26 23:07 EST | News | Neurocrine Biosciences: Ambitious Contender In The CNS Space | N/A |  |
| 2023-01-25 20:16 EST | News | Neurocrine Biosciences: Stencil In These Important Dates | N/A | |
| 2023-01-24 05:46 EST | News | Neurocrine Biosciences: Scope For Valuation Upside With Ingrezza Numbers | N/A | |
| 2023-01-21 19:15 EST | News | Stocks To Watch: Earnings Heat Up, Healthcare Catalysts And M&A Wildcards | N/A | |
| 2023-01-09 18:45 EST | News | Voyager jumps 29% on licensing deal with Neurocrine | N/A | |
| 2022-12-22 18:35 EST | News | FDA accepts Neurocrine's supplemental application for movement disorder treatment | N/A | |
| 2022-12-07 17:35 EST | News | Neurocrine says candidate for childhood epileptic disorder did not meet main goal | N/A | |
| 2022-11-04 23:25 EST | News | Neurocrine Biosciences Hands Out Treats For This Halloween Season | N/A | |
| 2022-11-01 13:00 EST | News | Neurocrine Biosciences Non-GAAP EPS of $1.08 misses by $0.04, revenue of $387.9M beats by $11.15M | N/A | |
| 2022-11-01 12:58 EST | News | Neurocrine Biosciences, Inc. (NBIX) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-01 12:58 EST | News | Neurocrine stock jumps on raised sales outlook for Ingrezza, Q3 revenue up 31% | N/A | |
| 2022-09-26 23:03 EST | News | Neurocrine initiated Equal Weight at Wells Fargo despite upcoming catalysts | N/A | |
| 2022-08-31 16:39 EST | News | Neurocrine Biosciences Goes Dumpster-Diving To Accelerate Its International Business Development | N/A | |
| 2022-08-30 07:41 EST | News | Neurocrine to acquire U.K.-based biotech Diurnal | N/A | |
| 2022-08-09 05:39 EST | News | Neurocrine Is Seeing A Very Welcome Pick Up In Ingrezza, But Pipeline Catalysts Are Thin | N/A | |
| 2022-08-05 21:30 EST | News | Neurocrine stock rises as Q2 revenue soars 31% Y/Y, raises sales outlook for Ingrezza | N/A | |
| 2022-08-05 05:42 EST | News | Neurocrine Biosciences Non-GAAP EPS of $0.84 misses by $0.05, revenue of $378.2M beats by $34.75M | N/A | |
| 2022-08-05 05:42 EST | News | Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-05 05:42 EST | News | Sosei to get $30M from Neurocrine as schizophrenia drug gets FDA nod to enter phase 2 trial | N/A | |
| 2022-08-03 23:49 EST | News | Neurocrine Biosciences Q2 2022 Earnings Preview | N/A | |
| 2022-07-19 05:38 EST | News | Better Ingrezza Sales And A Clinical Trial Read-Out Could Reignite Neurocrine Shares | N/A | |
| 2022-05-25 20:53 EST | News | Neurocrine Biosciences to repurchase $179.4M of 2.25% Convertible Senior Notes due 2024 | N/A | |
| 2022-05-15 20:45 EST | News | Global Blood, Impel Pharma could be M&A targets after Biohaven deal - analysts | N/A | |
| 2022-05-13 22:57 EST | News | Neurocrine Biosciences valbenazine gets FDA orphan drug status for Huntington disease | N/A | |
| 2022-05-07 05:15 EST | News | Neurocrine Biosciences, Inc. 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-05-05 06:43 EST | News | Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-04 09:49 EST | News | Neurocrine Biosciences Non-GAAP EPS of $0.30 misses by $0.29, revenue of $310.6M beats by $6.53M; reaffirms FY22 guidance | N/A | |
| 2022-05-03 18:09 EST | News | Neurocrine Biosciences Q1 2022 Earnings Preview | N/A | |
| 2022-03-04 08:40 EST | News | Neurocrine Biosciences cut to neutral at Piper on growth trajectory of Ingrezza | N/A | |
| 2022-02-16 04:09 EST | News | Neurocrine Biosciences Looking At A Year Of Heavy Lifting | N/A | |
| 2022-02-12 01:56 EST | News | Neurocrine Biosciences Non-GAAP EPS of $0.04 misses by $0.84, revenue of $312M misses by $5.72M | N/A | |
| 2022-02-12 01:56 EST | News | Neurocrine spikes to record biggest gain in 10 months despite quarterly miss | N/A | |
| 2022-02-12 01:56 EST | News | Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-10 12:26 EST | News | Neurocrine Biosciences Q4 2021 Earnings Preview | N/A | |
| 2022-01-30 11:31 EST | News | Neurocrine Biosciences: Taking Advantage Of A Shrinking Share Price Ahead Of Projected Growth | N/A | |
| 2022-01-28 11:00 EST | News | Aurinia Pharmaceuticals quick uptick on renewed takeover speculation on Biogen news | N/A | |
| 2022-01-25 00:02 EST | News | Neurocrine Biosciences (NBIX) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference | N/A | |
| 2022-01-19 00:25 EST | News | Neurocrine Biosciences downgraded at RBC on lack of near-term catalysts | N/A | |
| 2022-01-13 02:05 EST | News | Xenon passes regulatory mark to receive $15M from Neurocrine Biosciences | N/A | |
| 2022-01-07 08:00 EST | News | Neurocrine expects INGREZZA net sales to exceed $1B in 2021 | N/A | |
| 2021-12-09 05:13 EST | News | Neurocrine gains as Cantor calls valbenazine data “game changer” in Huntington's Disease | N/A | |
| 2021-12-08 10:15 EST | News | Neurocrine's Ingrezza meets primary endpoint in late-stage Huntington's trial | N/A | |
| 2021-12-01 05:41 EST | News | Neurocrine Biosciences picks former Eli Lilly executive as chief scientific officer | N/A | |
| 2021-11-23 04:54 EST | News | Neurocrine Biosciences in pact with Sosei for therapies targeting neuropsychiatric disorders | N/A | |
| 2021-11-18 19:37 EST | News | BMO initiates Neurocrine Biosciences at underperform on weak Ingrezza sales | N/A | |
| 2021-11-08 15:48 EST | News | Neurocrine Biosciences: Generic Drug Stock Seen As Underpriced By Market-Makers For Near Gains | N/A | |
| 2021-11-02 20:01 EST | News | Neurocrine defended by analysts despite Q3 miss | N/A | |
| 2021-11-02 00:53 EST | News | Neurocrine Biosciences EPS misses by $0.16, misses on revenue | N/A | |
| 2021-11-02 00:53 EST | News | Neurocrine swings to Q3 2021 profit, but EPS falls below expectations; shares down 6% | N/A | |
| 2021-11-02 00:53 EST | News | Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q3 2021 Results - Earnings Call Transcript | N/A | |
About Neurocrine Biosciences, Inc (NBIX):
Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological, endocrine, and psychiatric-based diseases and disorders in the United States. The company offers INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia; ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for adult patients with Parkinson's disease; ORILISSA, a gonadotropin-releasing hormone (GnRH) antagonist for the treatment of endometriosis pain; and ORIAHNN, a GnRH antagonist for the management of heavy menstrual bleeding associated with uterine fibroids. Its product candidates in clinical development include valbenazine, which is in Phase III clinical trial for the treatment of chorea in Huntington's disease; NBI-921352, a Nav1.6 sodium channel inhibitor for the treatment of pediatric patients with SCN8A-DEE, as well as other indications, such as adult focal epilepsy; NBI-827104, an orally active and brain penetrating T-type calcium channel blocker for the treatment of rare pediatric epilepsy and other indications; and NBI-74788, which is in Phase III clinical trial for the treatment of congenital adrenal hyperplasia. The company's products under development include NBI-1065844, a D-amino acid oxidase inhibitor for the treatment of negative symptoms of schizophrenia; NBI-1065845, an alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid potentiator for the treatment of resistant depression; and NBI-1065846, a G protein-coupled receptor 139 agonist for the treatment of anhedonia in depression. It has collaborations and agreements with Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL ? Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. Neurocrine Biosciences, Inc. was founded in 1992 and is headquartered in San Diego, California.
General
- Name Neurocrine Biosciences, Inc
- Symbol NBIX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 845
- Fiscal Year EndDecember
- IPO Date1996-05-23
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.neurocrine.com
View More
Valuation
- Trailing PE 22.26
- Forward PE 31.65
- Price/Sales (Trailing 12 Mt.) 8.84
- Price/Book (Most Recent Quarter) 7.89
- Enterprise Value Revenue 8.12
- Enterprise Value EBITDA 57.37
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $3.07
- Next Year EPS Estimate $4.75
- Next Quarter EPS Estimate $0.54
- Profit Margin 39%
- Operating Margin 31%
- Return on Assets 13%
- Return on Equity 46%
- Revenue 1.05 billion
- Earnings Per Share $4.16
- Revenue Per Share $11.23
- Gross Profit 760.8 million
- Quarterly Earnings Growth 1.6%
View More
Highlights
- Market Capitalization 8.7 billion
- EBITDA 336.1 million
- PE Ratio 178.81
- PEG Ratio 1.87
- Analyst Target Price $128.48
- Book Value Per Share $12.05
View More
Share Statistics
- Shares Outstanding 93.43 million
- Shares Float 92.65 million
- % Held by Insiders 126%
- % Held by Institutions 99.38%
- Shares Short 3.75 million
- Shares Short Prior Month 4.05 million
- Short Ratio 4.44
- Short % of Float 4%
- Short % of Shares Outstanding 4%
View More
Technicals
- Beta 0.83
- 52 Week High $136.26
- 52 Week Low $75.13
- 50 Day Moving Average 106.21
- 200 Day Moving Average 101.68
View More
Dividends
- Dividend Date N/A
- ExDividend Date 1995-12-29
- Dividend Yield 0%
View More
Neurocrine Biosciences, Inc (NBIX) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Neurocrine Biosciences, Inc (NBIX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-04 | $247.9 million | $0.91 | $0.90 | 1.06% |
| 2020-09-30 | 2020-11-09 | $N/A | $0.97 | $1.25 | -22.32% |
| 2020-06-30 | 2020-08-03 | $N/A | $1.42 | $1.02 | 39.13% |
| 2020-03-31 | 2020-05-06 | $N/A | $0.82 | $0.64 | 28.87% |
| 2019-12-31 | 2020-02-04 | $244.1 million | $0.35 | $0.75 | -53.3% |
| 2019-09-30 | 2019-11-04 | $222.09 million | $0.56 | $0.64 | -12.91% |
| 2019-06-30 | 2019-07-29 | $183.58 million | $0.54 | $0.25 | 112.51% |
| 2019-03-31 | 2019-04-29 | $138.4 million | -$1.12 | -$0.89 | -26% |
| 2018-12-31 | 2019-02-05 | $131.49 million | $0.19 | $0.19 | -0.47% |
| 2018-09-30 | 2018-11-05 | $151.76 million | $0.52 | $0.49 | 5.39% |
| 2018-06-30 | 2018-07-31 | $96.91 million | -$0.07 | -$0.18 | 60.38% |
| 2018-03-31 | 2018-04-30 | $71.09 million | -$0.47 | -$0.30 | -56.67% |
| 2017-12-31 | 2018-02-13 | $94.52 million | $0.07 | $0.16 | -56.71% |
| 2017-09-30 | 2017-11-01 | $60.77 million | -$0.13 | -$0.53 | 75.29% |
| 2017-06-30 | 2017-08-03 | $6.34 million | -$0.68 | -$0.65 | -4.76% |
| 2017-03-31 | 2017-05-09 | $N/A | -$0.90 | -$0.72 | -25.31% |
| 2016-12-31 | 2017-02-14 | $15 million | -$0.51 | -$0.55 | 7.54% |
| 2016-09-30 | 2016-11-02 | $15 million | -$0.43 | -$0.57 | 24.24% |
| 2016-06-30 | 2016-08-03 | $-30000000 | -$0.46 | -$0.49 | 6.67% |
| 2016-03-31 | 2016-05-05 | $15 million | -$0.22 | -$0.31 | 28.57% |
| 2015-12-31 | 2016-02-11 | $19.77 million | -$0.34 | -$0.35 | 3.55% |
| 2015-09-30 | 2015-10-29 | $N/A | -$0.40 | -$0.25 | -60% |
| 2015-06-30 | 2015-07-29 | $-19769000 | -$0.28 | -$0.29 | 3.45% |
| 2015-03-31 | 2015-04-30 | $19.77 million | -$0.01 | -$0.30 | 96.67% |
| 2014-12-31 | 2015-02-09 | $N/A | -$0.26 | -$0.24 | -8.33% |
| 2014-09-30 | 2014-11-03 | $N/A | -$0.21 | -$0.21 | 0% |
| 2014-06-30 | 2014-08-06 | $N/A | -$0.18 | -$0.18 | 0% |
| 2014-03-31 | 2014-04-30 | $N/A | -$0.17 | -$0.19 | 10.53% |
| 2013-12-31 | 2014-02-06 | $730000 | -$0.16 | -$0.17 | 5.88% |
| 2013-09-30 | 2013-10-29 | $729000 | -$0.17 | -$0.20 | 15% |
| 2013-06-30 | 2013-07-25 | $730000 | -$0.18 | -$0.19 | 5.26% |
| 2013-03-31 | 2013-05-02 | $730000 | -$0.18 | -$0.18 | 0% |
| 2012-12-31 | 2013-02-08 | $21.95 million | $0.14 | -$0.08 | 275% |
| 2012-09-30 | 2012-10-31 | $9.36 million | -$0.05 | -$0.05 | 0% |
| 2012-06-30 | 2012-07-31 | $10.57 million | -$0.01 | -$0.03 | 66.67% |
| 2012-03-31 | 2012-05-02 | $11.27 million | -$0.01 | -$0.01 | 0% |
| 2011-12-31 | 2012-02-08 | $11.11 million | $0.02 | $0.02 | 0% |
| 2011-09-30 | 2011-10-31 | $41.63 million | $0.56 | $0.19 | 194.74% |
| 2011-06-30 | 2011-07-28 | $12.16 million | $0.04 | $0.06 | -33.33% |
| 2011-03-31 | 2011-05-03 | $12.51 million | $0.05 | $0.05 | 0% |
| 2010-12-31 | 2011-02-10 | $13.66 million | $0.04 | $0.04 | 0% |
| 2010-09-30 | 2010-10-28 | $14.45 million | $0.06 | $0.05 | 20% |
| 2010-06-30 | 2010-07-28 | $4.64 million | -$0.09 | -$0.17 | 47.06% |
| 2010-03-31 | 2010-04-28 | $753000 | -$0.19 | -$0.24 | 20.83% |
| 2009-12-31 | 2010-02-03 | $740000 | -$0.20 | -$0.27 | 25.93% |
| 2009-09-30 | 2009-10-28 | $733000 | -$0.21 | -$0.35 | 40% |
| 2009-06-30 | 2009-07-29 | $733000 | -$0.39 | -$0.40 | 2.5% |
| 2009-03-31 | 2009-05-05 | $747000 | -$0.51 | -$0.39 | -30.77% |
| 2008-12-31 | 2009-02-03 | $729000 | -$0.75 | -$0.50 | -50% |
| 2008-09-30 | 2008-10-28 | $761000 | -$0.46 | -$0.51 | 9.8% |
| 2008-06-30 | 2008-07-30 | $734000 | -$0.55 | -$0.52 | -5.77% |
| 2008-03-31 | 2008-04-30 | $1.75 million | -$0.55 | -$0.55 | 0% |
| 2007-12-31 | 2008-02-05 | $532000 | -$0.89 | -$0.85 | -4.71% |
| 2007-09-30 | 2007-11-01 | $540000 | -$0.72 | -$0.78 | 7.69% |
| 2007-06-30 | 2007-07-31 | $48000 | -$0.69 | -$0.73 | 5.48% |
| 2007-03-31 | 2007-05-03 | $104000 | -$0.68 | -$0.66 | -3.03% |
| 2006-12-31 | 2007-02-01 | $9.44 million | -$0.39 | -$0.76 | 48.68% |
| 2006-09-30 | 2006-11-02 | $1.07 million | -$1.03 | -$0.91 | -13.19% |
| 2006-06-30 | 2006-07-17 | $9.24 million | -$0.73 | -$0.72 | -1.39% |
| 2006-03-31 | 2006-04-24 | $19.48 million | -$0.69 | -$0.63 | -9.52% |
| 2005-12-31 | 2006-01-23 | $14.11 million | -$0.65 | -$0.70 | 7.14% |
| 2005-09-30 | 2005-10-24 | $64.75 million | $0.68 | $0.48 | 41.67% |
| 2005-06-30 | 2005-08-03 | $33.17 million | -$0.15 | -$0.24 | 37.5% |
| 2005-03-31 | 2005-04-28 | $11.86 million | -$0.51 | -$0.64 | 20.31% |
| 2004-12-31 | 2005-02-10 | $18.49 million | -$0.57 | -$0.35 | -62.86% |
| 2004-09-30 | 2004-11-01 | $34.7 million | -$0.05 | -$0.39 | 87.18% |
| 2004-06-30 | 2004-07-28 | $15.05 million | -$0.31 | -$0.27 | -14.81% |
| 2004-03-31 | 2004-05-03 | $16.94 million | -$0.35 | -$0.36 | 2.78% |
| 2003-12-31 | 2004-01-29 | $27.14 million | $0.09 | -$0.14 | 164.29% |
| 2003-09-30 | 2003-11-03 | $29.26 million | -$0.31 | -$0.36 | 13.89% |
| 2003-06-30 | 2003-07-24 | $44.97 million | -$0.33 | -$0.38 | 13.16% |
| 2003-03-31 | 2003-04-29 | $37.72 million | -$0.43 | -$0.38 | -13.16% |
| 2002-12-31 | 2003-02-03 | $3.88 million | -$1.27 | -$0.85 | -49.41% |
| 2002-09-30 | 2002-10-30 | $4.98 million | -$0.66 | -$0.81 | 18.52% |
| 2002-06-30 | 2002-07-30 | $4.23 million | -$0.65 | -$0.68 | 4.41% |
| 2002-03-31 | 2002-04-29 | $4.96 million | -$0.52 | -$0.66 | 21.21% |
| 2001-12-31 | 2002-02-05 | $12.83 million | -$0.53 | -$0.50 | -6% |
| 2001-09-30 | 2001-11-01 | $21.59 million | $0.09 | -$0.30 | 130% |
| 2001-06-30 | 2001-07-31 | $3.33 million | -$0.52 | -$0.62 | 16.13% |
| 2001-03-31 | 2001-04-30 | $3.49 million | -$0.45 | -$0.56 | 19.64% |
| 2000-12-31 | 2001-01-30 | $6.44 million | -$0.29 | -$0.41 | 29.27% |
| 2000-09-30 | 2000-11-02 | $2.43 million | -$0.37 | -$0.13 | -184.62% |
| 2000-06-30 | 2000-07-28 | $2.94 million | -$0.24 | -$0.17 | -41.18% |
| 2000-03-31 | 2000-04-27 | $2.78 million | -$0.28 | -$0.37 | 24.32% |
| 1999-12-31 | 2000-02-14 | -$0.19 | -$0.25 | 24% | |
| 1999-09-30 | 1999-11-01 | -$0.23 | -$0.23 | 0% | |
| 1999-06-30 | 1999-08-03 | -$0.24 | -$0.22 | -9.09% | |
| 1999-03-31 | 1999-05-05 | -$0.22 | -$0.09 | -144.44% | |
| 1998-12-31 | 1999-03-05 | -$0.18 | $0.00 | ||
| 1998-09-30 | 1998-11-02 | -$0.22 | -$0.19 | -15.79% | |
| 1998-06-30 | 1998-08-04 | -$0.14 | -$0.17 | 17.65% | |
| 1998-03-31 | 1998-05-04 | -$0.07 | -$0.04 | -75% | |
| 1997-12-31 | 1998-02-17 | $0.00 | -$0.01 | 100% | |
| 1997-09-30 | 1997-10-31 | $0.06 | $0.05 | 20% | |
| 1997-06-30 | 1997-07-31 | $0.01 | -$0.02 | 150% | |
| 1997-03-31 | 1997-04-24 | $0.23 | $0.12 | 91.67% | |
| 1996-12-31 | 1997-02-03 | $0.24 | $0.21 | 14.29% | |
| 1996-09-30 | 1996-11-04 | -$0.02 | $0.03 | -166.67% | |
| 1996-06-30 | 1996-07-31 | $0.11 | $0.04 | 175% |
Neurocrine Biosciences, Inc (NBIX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Neurocrine Biosciences, Inc (NBIX) Chart:
Neurocrine Biosciences, Inc (NBIX) News:
Below you will find a list of latest news for Neurocrine Biosciences, Inc (NBIX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Neurocrine Biosciences, Inc (NBIX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2023-02-17 | 50 | 0 | CALL | 254.99 | TRUE | 0 | 0 | ||
| 2023-02-17 | 55 | 0 | CALL | 25 | 228.06 | TRUE | 0 | 0 | |
| 2023-02-17 | 60 | 59.6 | CALL | 2 | 1 | 200.71 | TRUE | 0 | 0 |
| 2023-02-17 | 65 | 0 | CALL | 188.43 | TRUE | 0 | 0 | ||
| 2023-02-17 | 70 | 51 | CALL | 2 | 8 | 81.81 | TRUE | 0 | 0 |
| 2023-02-17 | 75 | 46.3 | CALL | 1 | 1 | 56.99 | TRUE | 0 | 0 |
| 2023-02-17 | 80 | 36 | CALL | 4 | 4 | 65.91 | TRUE | 0 | 0 |
| 2023-02-17 | 85 | 24.1 | CALL | 2 | 3 | 53.73 | TRUE | 0 | 0 |
| 2023-02-17 | 90 | 20.25 | CALL | 1 | 1 | 49.05 | TRUE | 0 | 0 |
| 2023-02-17 | 95 | 16.45 | CALL | 3 | 45.88 | TRUE | 0 | 0 | |
| 2023-02-17 | 100 | 12 | CALL | 5 | 47 | 39.41 | TRUE | 0 | 0 |
| 2023-02-17 | 105 | 10.74 | CALL | 1 | 11 | 41.37 | TRUE | 0 | 0 |
| 2023-02-17 | 110 | 3.14 | CALL | 5 | 23 | 29.56 | FALSE | 0 | 0 |
| 2023-02-17 | 115 | 1.7 | CALL | 1 | 42 | 38.99 | FALSE | 0.29 | 0.21 |
| 2023-02-17 | 120 | 0.49 | CALL | 1 | 1980 | 33.78 | FALSE | 0 | 0 |
| 2023-02-17 | 125 | 2.15 | CALL | 1 | 24 | 37.97 | FALSE | 0 | 0 |
| 2023-02-17 | 130 | 0.16 | CALL | 3 | 37 | 40.92 | FALSE | 0 | 0 |
| 2023-02-17 | 135 | 0.1 | CALL | 4 | 29 | 0 | FALSE | 0 | 0 |
| 2023-02-17 | 140 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2023-02-17 | 145 | 2.47 | CALL | 1 | 0 | FALSE | 0 | 0 | |
| 2023-02-17 | 150 | 2.1 | CALL | 3 | 3 | 0 | FALSE | 0 | 0 |
| 2023-02-17 | 155 | 1.29 | CALL | 1 | 2 | 0 | FALSE | 0 | 0 |
| 2023-02-17 | 160 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2023-02-17 | 165 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2023-02-17 | 170 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2023-02-17 | 175 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2023-02-17 | 180 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2023-02-17 | 185 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2023-02-17 | 50 | 0 | PUT | 0 | FALSE | 0 | 0 | ||
| 2023-02-17 | 55 | 0 | PUT | 1 | 0 | FALSE | 0 | 0 | |
| 2023-02-17 | 60 | 0.4 | PUT | 11 | 10 | 0 | FALSE | 0 | 0 |
| 2023-02-17 | 65 | 0 | PUT | 0 | FALSE | 0 | 0 | ||
| 2023-02-17 | 70 | 0 | PUT | 2 | 0 | FALSE | 0 | 0 | |
| 2023-02-17 | 75 | 0 | PUT | 4 | 0 | FALSE | 0 | 0 | |
| 2023-02-17 | 80 | 0 | PUT | 0 | FALSE | 0 | 0 | ||
| 2023-02-17 | 85 | 0.3 | PUT | 10 | 16 | 0 | FALSE | 0 | 0 |
| 2023-02-17 | 90 | 0.55 | PUT | 1 | 23 | 92.43 | FALSE | 0 | 0 |
| 2023-02-17 | 95 | 0.66 | PUT | 3 | 12 | 68.98 | FALSE | 0 | 0 |
| 2023-02-17 | 100 | 2.32 | PUT | 2 | 16 | 53.86 | FALSE | 0 | 0 |
| 2023-02-17 | 105 | 3.38 | PUT | 1 | 6 | 32.43 | FALSE | 0 | 0 |
| 2023-02-17 | 110 | 5 | PUT | 1 | 15 | 33.69 | TRUE | 0 | 0 |
| 2023-02-17 | 115 | 10 | PUT | 1 | 5 | 32.88 | TRUE | 0 | 0 |
| 2023-02-17 | 120 | 12.3 | PUT | 5 | 17 | 52.07 | TRUE | 0 | 0 |
| 2023-02-17 | 125 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2023-02-17 | 130 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2023-02-17 | 135 | 12.4 | PUT | 1 | 0 | TRUE | 0 | 0 | |
| 2023-02-17 | 140 | 0 | PUT | 64.41 | TRUE | 0 | 0 | ||
| 2023-02-17 | 145 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2023-02-17 | 150 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2023-02-17 | 155 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2023-02-17 | 160 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2023-02-17 | 165 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2023-02-17 | 170 | 0 | PUT | 95.22 | TRUE | 0 | 0 | ||
| 2023-02-17 | 175 | 0 | PUT | 95.97 | TRUE | 0 | 0 | ||
| 2023-02-17 | 180 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2023-02-17 | 185 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2023-03-17 | 55 | 0 | CALL | 68.67 | TRUE | 0 | 0 | ||
| 2023-03-17 | 60 | 0 | CALL | 135.04 | TRUE | 0 | 0 | ||
| 2023-03-17 | 65 | 0 | CALL | 48.53 | TRUE | 0 | 0 | ||
| 2023-03-17 | 70 | 0 | CALL | 58.69 | TRUE | 0 | 0 | ||
| 2023-03-17 | 75 | 0 | CALL | 43.97 | TRUE | 0 | 0 | ||
| 2023-03-17 | 80 | 0 | CALL | 51.83 | TRUE | 0 | 0 | ||
| 2023-03-17 | 85 | 0 | CALL | 48.17 | TRUE | 0 | 0 | ||
| 2023-03-17 | 90 | 0 | CALL | 48.3 | TRUE | 0 | 0 | ||
| 2023-03-17 | 95 | 0 | CALL | 45.71 | TRUE | 0 | 0 | ||
| 2023-03-17 | 100 | 13 | CALL | 4 | 42.46 | TRUE | 0 | 0 | |
| 2023-03-17 | 105 | 0 | CALL | 40.12 | TRUE | 0 | 0 | ||
| 2023-03-17 | 110 | 5.3 | CALL | 1 | 33.86 | FALSE | 0 | 0 | |
| 2023-03-17 | 115 | 0 | CALL | 28.29 | FALSE | 0 | 0 | ||
| 2023-03-17 | 120 | 0 | CALL | 30.14 | FALSE | 0 | 0 | ||
| 2023-03-17 | 125 | 0.55 | CALL | 1 | 29.45 | FALSE | 0 | 0 | |
| 2023-03-17 | 130 | 0 | CALL | 30.95 | FALSE | 0 | 0 | ||
| 2023-03-17 | 135 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2023-03-17 | 140 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2023-03-17 | 145 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2023-03-17 | 150 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2023-03-17 | 155 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2023-03-17 | 160 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2023-03-17 | 165 | 0 | CALL | 0 | FALSE | 0 | 0 | ||
| 2023-03-17 | 55 | 0 | PUT | 0 | FALSE | 0 | 0 | ||
| 2023-03-17 | 60 | 0 | PUT | 0 | FALSE | 0 | 0 | ||
| 2023-03-17 | 65 | 0 | PUT | 0 | FALSE | 0 | 0 | ||
| 2023-03-17 | 70 | 0 | PUT | 0 | FALSE | 0 | 0 | ||
| 2023-03-17 | 75 | 0 | PUT | 98.33 | FALSE | 0 | 0 | ||
| 2023-03-17 | 80 | 0 | PUT | 86.3 | FALSE | 0 | 0 | ||
| 2023-03-17 | 85 | 0 | PUT | 73.85 | FALSE | 0 | 0 | ||
| 2023-03-17 | 90 | 0.71 | PUT | 3 | 52.67 | FALSE | 0 | 0 | |
| 2023-03-17 | 95 | 0 | PUT | 50.02 | FALSE | 0 | 0 | ||
| 2023-03-17 | 100 | 0 | PUT | 41.56 | FALSE | 0 | 0 | ||
| 2023-03-17 | 105 | 0 | PUT | 36.92 | FALSE | 0 | 0 | ||
| 2023-03-17 | 110 | 0 | PUT | 31 | TRUE | 0 | 0 | ||
| 2023-03-17 | 115 | 0 | PUT | 31.35 | TRUE | 0 | 0 | ||
| 2023-03-17 | 120 | 0 | PUT | 33.4 | TRUE | 0 | 0 | ||
| 2023-03-17 | 125 | 0 | PUT | 33.91 | TRUE | 0 | 0 | ||
| 2023-03-17 | 130 | 0 | PUT | 48.57 | TRUE | 0 | 0 | ||
| 2023-03-17 | 135 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2023-03-17 | 140 | 0 | PUT | 46.81 | TRUE | 0 | 0 | ||
| 2023-03-17 | 145 | 0 | PUT | 48.89 | TRUE | 0 | 0 | ||
| 2023-03-17 | 150 | 0 | PUT | 53.38 | TRUE | 0 | 0 | ||
| 2023-03-17 | 155 | 0 | PUT | 59.36 | TRUE | 0 | 0 | ||
| 2023-03-17 | 160 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2023-03-17 | 165 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2023-05-19 | 55 | 0 | CALL | 57.07 | TRUE | 0 | 0 | ||
| 2023-05-19 | 60 | 63 | CALL | 1 | 1 | 54.5 | TRUE | 0 | 0 |
| 2023-05-19 | 65 | 0 | CALL | 50.8 | TRUE | 0 | 0 | ||
| 2023-05-19 | 70 | 0 | CALL | 47.77 | TRUE | 0 | 0 | ||
| 2023-05-19 | 75 | 0 | CALL | 45.62 | TRUE | 0 | 0 | ||
| 2023-05-19 | 80 | 38.6 | CALL | 1 | 45.78 | TRUE | 0 | 0 | |
| 2023-05-19 | 85 | 0 | CALL | 39.24 | TRUE | 0 | 0 | ||
| 2023-05-19 | 90 | 23.04 | CALL | 7 | 39.4 | TRUE | 0 | 0 | |
| 2023-05-19 | 95 | 0 | CALL | 1 | 1 | 34.76 | TRUE | 0 | 0 |
| 2023-05-19 | 100 | 31 | CALL | 1 | 4 | 36.24 | TRUE | 0 | 0 |
| 2023-05-19 | 105 | 11 | CALL | 4 | 9 | 36.2 | TRUE | -1 | -0.08 |
| 2023-05-19 | 110 | 9.5 | CALL | 3 | 17 | 33.58 | FALSE | 0 | 0 |
| 2023-05-19 | 115 | 6.9 | CALL | 3 | 27 | 31.37 | FALSE | 0 | 0 |
| 2023-05-19 | 120 | 12.2 | CALL | 2 | 197 | 30.16 | FALSE | 0 | 0 |
| 2023-05-19 | 125 | 2.1 | CALL | 4 | 479 | 29.4 | FALSE | 0 | 0 |
| 2023-05-19 | 130 | 1.7 | CALL | 1 | 32 | 30.91 | FALSE | 1 | 1.43 |
| 2023-05-19 | 135 | 1.35 | CALL | 1 | 23 | 39.54 | FALSE | 0 | 0 |
| 2023-05-19 | 140 | 8.4 | CALL | 2 | 37 | 42.07 | FALSE | 0 | 0 |
| 2023-05-19 | 145 | 1.5 | CALL | 1 | 7 | 49.25 | FALSE | 0 | 0 |
| 2023-05-19 | 150 | 2.7 | CALL | 2 | 6 | 52.43 | FALSE | 0 | 0 |
| 2023-05-19 | 155 | 0 | CALL | 54.68 | FALSE | 0 | 0 | ||
| 2023-05-19 | 160 | 3 | CALL | 5 | 14 | 58.61 | FALSE | 0 | 0 |
| 2023-05-19 | 165 | 1 | CALL | 1 | 1 | 61.52 | FALSE | 0 | 0 |
| 2023-05-19 | 170 | 0 | CALL | 64.27 | FALSE | 0 | 0 | ||
| 2023-05-19 | 175 | 0 | CALL | 67.07 | FALSE | 0 | 0 | ||
| 2023-05-19 | 180 | 1.25 | CALL | 1 | 69.75 | FALSE | 0 | 0 | |
| 2023-05-19 | 185 | 2.4 | CALL | 2 | 2 | 63.39 | FALSE | 0 | 0 |
| 2023-05-19 | 55 | 0 | PUT | 106.11 | FALSE | 0 | 0 | ||
| 2023-05-19 | 60 | 0 | PUT | 95.69 | FALSE | 0 | 0 | ||
| 2023-05-19 | 65 | 0 | PUT | 86.04 | FALSE | 0 | 0 | ||
| 2023-05-19 | 70 | 1.3 | PUT | 1 | 11 | 75.1 | FALSE | 0 | 0 |
| 2023-05-19 | 75 | 1.65 | PUT | 1 | 1 | 65.84 | FALSE | 0 | 0 |
| 2023-05-19 | 80 | 0 | PUT | 56.29 | FALSE | 0 | 0 | ||
| 2023-05-19 | 85 | 0 | PUT | 49.37 | FALSE | 0 | 0 | ||
| 2023-05-19 | 90 | 0 | PUT | 3 | 4 | 39.43 | FALSE | 0 | 0 |
| 2023-05-19 | 95 | 0 | PUT | 34.85 | FALSE | 0 | 0 | ||
| 2023-05-19 | 100 | 4.3 | PUT | 5 | 11 | 32.69 | FALSE | 0 | 0 |
| 2023-05-19 | 105 | 5.1 | PUT | 1 | 11 | 32.86 | FALSE | 0 | 0 |
| 2023-05-19 | 110 | 8.5 | PUT | 1 | 1 | 30.68 | TRUE | 0 | 0 |
| 2023-05-19 | 115 | 8.67 | PUT | 10 | 30.28 | TRUE | 0 | 0 | |
| 2023-05-19 | 120 | 0 | PUT | 29.26 | TRUE | 0 | 0 | ||
| 2023-05-19 | 125 | 16.9 | PUT | 2 | 3 | 28.33 | TRUE | 0 | 0 |
| 2023-05-19 | 130 | 0 | PUT | 29.55 | TRUE | 0 | 0 | ||
| 2023-05-19 | 135 | 0 | PUT | 43.57 | TRUE | 0 | 0 | ||
| 2023-05-19 | 140 | 29.63 | PUT | 1 | 6 | 48.6 | TRUE | 0 | 0 |
| 2023-05-19 | 145 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2023-05-19 | 150 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2023-05-19 | 155 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2023-05-19 | 160 | 0 | PUT | 63.22 | TRUE | 0 | 0 | ||
| 2023-05-19 | 165 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2023-05-19 | 170 | 0 | PUT | 71.23 | TRUE | 0 | 0 | ||
| 2023-05-19 | 175 | 0 | PUT | 0 | TRUE | 0 | 0 | ||
| 2023-05-19 | 180 | 0 | PUT | 75.81 | TRUE | 0 | 0 | ||
| 2023-05-19 | 185 | 0 | PUT | 58.48 | TRUE | 0 | 0 | ||
| 2023-08-18 | 55 | 0 | CALL | 55.51 | TRUE | 0 | 0 | ||
| 2023-08-18 | 60 | 0 | CALL | 48.92 | TRUE | 0 | 0 | ||
| 2023-08-18 | 65 | 0 | CALL | 45.24 | TRUE | 0 | 0 | ||
| 2023-08-18 | 70 | 0 | CALL | 41.43 | TRUE | 0 | 0 | ||
| 2023-08-18 | 75 | 37 | CALL | 1 | 39.98 | TRUE | 0 | 0 | |
| 2023-08-18 | 80 | 0 | CALL | 39.41 | TRUE | 0 | 0 | ||
| 2023-08-18 | 85 | 0 | CALL | 38.21 | TRUE | 0 | 0 | ||
| 2023-08-18 | 90 | 0 | CALL | 35.1 | TRUE | 0 | 0 | ||
| 2023-08-18 | 95 | 20.7 | CALL | 1 | 34.85 | TRUE | 0 | 0 | |
| 2023-08-18 | 100 | 17.85 | CALL | 2 | 4 | 32.86 | TRUE | 0 | 0 |
| 2023-08-18 | 105 | 0 | CALL | 32.49 | TRUE | 0 | 0 | ||
| 2023-08-18 | 110 | 0 | CALL | 28.77 | FALSE | 0 | 0 | ||
| 2023-08-18 | 115 | 7.1 | CALL | 5 | 21 | 27.11 | FALSE | -2.41 | -0.25 |
| 2023-08-18 | 120 | 6 | CALL | 1 | 12 | 30.08 | FALSE | 0 | 0 |
| 2023-08-18 | 125 | 6.3 | CALL | 1 | 28.98 | FALSE | 0 | 0 | |
| 2023-08-18 | 130 | 10 | CALL | 2 | 27.41 | FALSE | 0 | 0 | |
| 2023-08-18 | 135 | 0 | CALL | 29.54 | FALSE | 0 | 0 | ||
| 2023-08-18 | 140 | 0 | CALL | 32.03 | FALSE | 0 | 0 | ||
| 2023-08-18 | 145 | 6.1 | CALL | 1 | 33.76 | FALSE | 0 | 0 | |
| 2023-08-18 | 150 | 5.5 | CALL | 1 | 31.97 | FALSE | 0 | 0 | |
| 2023-08-18 | 155 | 1.55 | CALL | 10 | 38.84 | FALSE | 0 | 0 | |
| 2023-08-18 | 160 | 0 | CALL | 42.02 | FALSE | 0 | 0 | ||
| 2023-08-18 | 165 | 0 | CALL | 44.44 | FALSE | 0 | 0 | ||
| 2023-08-18 | 170 | 0 | CALL | 46.62 | FALSE | 0 | 0 | ||
| 2023-08-18 | 175 | 0 | CALL | 50.33 | FALSE | 0 | 0 | ||
| 2023-08-18 | 55 | 0 | PUT | 78.52 | FALSE | 0 | 0 | ||
| 2023-08-18 | 60 | 0 | PUT | 70.69 | FALSE | 0 | 0 | ||
| 2023-08-18 | 65 | 0 | PUT | 63.65 | FALSE | 0 | 0 | ||
| 2023-08-18 | 70 | 0 | PUT | 56.34 | FALSE | 0 | 0 | ||
| 2023-08-18 | 75 | 0 | PUT | 50.18 | FALSE | 0 | 0 | ||
| 2023-08-18 | 80 | 0 | PUT | 43.69 | FALSE | 0 | 0 | ||
| 2023-08-18 | 85 | 0 | PUT | 38.5 | FALSE | 0 | 0 | ||
| 2023-08-18 | 90 | 0 | PUT | 35.65 | FALSE | 0 | 0 | ||
| 2023-08-18 | 95 | 0 | PUT | 33.68 | FALSE | 0 | 0 | ||
| 2023-08-18 | 100 | 0 | PUT | 32.76 | FALSE | 0 | 0 | ||
| 2023-08-18 | 105 | 7.7 | PUT | 1 | 30.8 | FALSE | 0 | 0 | |
| 2023-08-18 | 110 | 9.6 | PUT | 5 | 753 | 31.06 | TRUE | 0 | 0 |
| 2023-08-18 | 115 | 9.3 | PUT | 10 | 28.41 | TRUE | 0 | 0 | |
| 2023-08-18 | 120 | 15.65 | PUT | 1 | 29.03 | TRUE | 0 | 0 | |
| 2023-08-18 | 125 | 0 | PUT | 28.1 | TRUE | 0 | 0 | ||
| 2023-08-18 | 130 | 22.37 | PUT | 3 | 28.94 | TRUE | 0 | 0 | |
| 2023-08-18 | 135 | 0 | PUT | 28.59 | TRUE | 0 | 0 | ||
| 2023-08-18 | 140 | 0 | PUT | 28.57 | TRUE | 0 | 0 | ||
| 2023-08-18 | 145 | 0 | PUT | 43.93 | TRUE | 0 | 0 | ||
| 2023-08-18 | 150 | 0 | PUT | 46.14 | TRUE | 0 | 0 | ||
| 2023-08-18 | 155 | 0 | PUT | 49.09 | TRUE | 0 | 0 | ||
| 2023-08-18 | 160 | 0 | PUT | 39.09 | TRUE | 0 | 0 | ||
| 2023-08-18 | 165 | 0 | PUT | 54.59 | TRUE | 0 | 0 | ||
| 2023-08-18 | 170 | 0 | PUT | 57.16 | TRUE | 0 | 0 | ||
| 2023-08-18 | 175 | 0 | PUT | 60.14 | TRUE | 0 | 0 |
Latest NBIX Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 1 | $91.51 |
| Jun 13, 2022 7:59 PM EST | 33 | $91.47 |
| Jun 13, 2022 7:59 PM EST | 75 | $91.47 |
| Jun 13, 2022 7:59 PM EST | 1 | $91.47 |
| Jun 13, 2022 7:59 PM EST | 100 | $91.48 |
Neurocrine Biosciences, Inc (NBIX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120038896/0001209191-20-038896-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/914475/000008025519002390/0000080255-19-002390-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/914475/000008025520001009/0000080255-20-001009-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/914475/000021545719007306/0000215457-19-007306-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/914475/000031506619001231/0000315066-19-001231-index.htm |
| 2019-12-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/914475/000031506619001815/0000315066-19-001815-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/914475/000031506620001121/0000315066-20-001121-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/914475/000083423720008722/0000834237-20-008722-index.htm |
| 2020-07-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000091447520000005/0000914475-20-000005-index.htm |
| 2020-08-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000091447520000017/0000914475-20-000017-index.htm |
| 2020-08-03 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/914475/000091447520000018/0000914475-20-000018-index.htm |
| 2020-08-03 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/914475/000091447520000020/0000914475-20-000020-index.htm |
| 2020-08-03 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/914475/000091447520000022/0000914475-20-000022-index.htm |
| 2020-08-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000091447520000025/0000914475-20-000025-index.htm |
| 2020-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000091447520000029/0000914475-20-000029-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/914475/000093247119005517/0000932471-19-005517-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/914475/000110465920017955/0001104659-20-017955-index.htm |
| 2018-12-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000119312518347337/0001193125-18-347337-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000119312519003238/0001193125-19-003238-index.htm |
| 2019-01-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000119312519019701/0001193125-19-019701-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/914475/000119312519041013/0001193125-19-041013-index.htm |
| 2019-04-17 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/914475/000119312519109100/0001193125-19-109100-index.htm |
| 2019-04-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000119312519121779/0001193125-19-121779-index.htm |
| 2019-05-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000119312519155346/0001193125-19-155346-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/914475/000119312520038181/0001193125-20-038181-index.htm |
| 2020-07-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000119312520191864/0001193125-20-191864-index.htm |
| 2018-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919118058377/0001209191-18-058377-index.htm |
| 2018-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919118060053/0001209191-18-060053-index.htm |
| 2018-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919118061372/0001209191-18-061372-index.htm |
| 2019-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119003276/0001209191-19-003276-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119007846/0001209191-19-007846-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119007847/0001209191-19-007847-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119007849/0001209191-19-007849-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119007850/0001209191-19-007850-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119007851/0001209191-19-007851-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119007852/0001209191-19-007852-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119007854/0001209191-19-007854-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119008625/0001209191-19-008625-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119008628/0001209191-19-008628-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119008629/0001209191-19-008629-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119008630/0001209191-19-008630-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119008635/0001209191-19-008635-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119008638/0001209191-19-008638-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119008639/0001209191-19-008639-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119008643/0001209191-19-008643-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119008648/0001209191-19-008648-index.htm |
| 2019-03-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119019450/0001209191-19-019450-index.htm |
| 2019-03-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119019459/0001209191-19-019459-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119030172/0001209191-19-030172-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119030173/0001209191-19-030173-index.htm |
| 2019-05-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119031107/0001209191-19-031107-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119031531/0001209191-19-031531-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119032383/0001209191-19-032383-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119032388/0001209191-19-032388-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119032394/0001209191-19-032394-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119032399/0001209191-19-032399-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119032402/0001209191-19-032402-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119032407/0001209191-19-032407-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119032451/0001209191-19-032451-index.htm |
| 2019-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119033260/0001209191-19-033260-index.htm |
| 2019-06-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119034056/0001209191-19-034056-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119034913/0001209191-19-034913-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119037472/0001209191-19-037472-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119038288/0001209191-19-038288-index.htm |
| 2019-07-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119041925/0001209191-19-041925-index.htm |
| 2019-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119042520/0001209191-19-042520-index.htm |
| 2019-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119042522/0001209191-19-042522-index.htm |
| 2019-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119043914/0001209191-19-043914-index.htm |
| 2019-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119043916/0001209191-19-043916-index.htm |
| 2019-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119043918/0001209191-19-043918-index.htm |
| 2019-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119043920/0001209191-19-043920-index.htm |
| 2019-08-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119045228/0001209191-19-045228-index.htm |
| 2019-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119045763/0001209191-19-045763-index.htm |
| 2019-08-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119047571/0001209191-19-047571-index.htm |
| 2019-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119048482/0001209191-19-048482-index.htm |
| 2019-09-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119049287/0001209191-19-049287-index.htm |
| 2019-09-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119049291/0001209191-19-049291-index.htm |
| 2019-10-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119052596/0001209191-19-052596-index.htm |
| 2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119053286/0001209191-19-053286-index.htm |
| 2019-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119055228/0001209191-19-055228-index.htm |
| 2019-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119055235/0001209191-19-055235-index.htm |
| 2019-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119056381/0001209191-19-056381-index.htm |
| 2019-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119056385/0001209191-19-056385-index.htm |
| 2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119057272/0001209191-19-057272-index.htm |
| 2019-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919119059146/0001209191-19-059146-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120003043/0001209191-20-003043-index.htm |
| 2020-02-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120006364/0001209191-20-006364-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120006379/0001209191-20-006379-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120007671/0001209191-20-007671-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120007674/0001209191-20-007674-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120007676/0001209191-20-007676-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120007678/0001209191-20-007678-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120007681/0001209191-20-007681-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120007683/0001209191-20-007683-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120007686/0001209191-20-007686-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120007688/0001209191-20-007688-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120007691/0001209191-20-007691-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120007695/0001209191-20-007695-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120008478/0001209191-20-008478-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120008481/0001209191-20-008481-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120008484/0001209191-20-008484-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120008487/0001209191-20-008487-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120008491/0001209191-20-008491-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120008494/0001209191-20-008494-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120008498/0001209191-20-008498-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120008503/0001209191-20-008503-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120008513/0001209191-20-008513-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120008518/0001209191-20-008518-index.htm |
| 2020-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120025028/0001209191-20-025028-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120026062/0001209191-20-026062-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120026063/0001209191-20-026063-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120026064/0001209191-20-026064-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120026065/0001209191-20-026065-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120026066/0001209191-20-026066-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120026068/0001209191-20-026068-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120026069/0001209191-20-026069-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120026070/0001209191-20-026070-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120026071/0001209191-20-026071-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120026072/0001209191-20-026072-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120026302/0001209191-20-026302-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120026306/0001209191-20-026306-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120028392/0001209191-20-028392-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120028394/0001209191-20-028394-index.htm |
| 2020-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120029401/0001209191-20-029401-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120031028/0001209191-20-031028-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120031033/0001209191-20-031033-index.htm |
| 2020-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120031463/0001209191-20-031463-index.htm |
| 2020-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120031486/0001209191-20-031486-index.htm |
| 2020-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120031493/0001209191-20-031493-index.htm |
| 2020-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120031496/0001209191-20-031496-index.htm |
| 2020-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120031499/0001209191-20-031499-index.htm |
| 2020-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120031502/0001209191-20-031502-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120036698/0001209191-20-036698-index.htm |
| 2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120038890/0001209191-20-038890-index.htm |
| 2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120038896/0001209191-20-038896-index.htm |
| 2020-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120042167/0001209191-20-042167-index.htm |
| 2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120045716/0001209191-20-045716-index.htm |
| 2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120045725/0001209191-20-045725-index.htm |
| 2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120045742/0001209191-20-045742-index.htm |
| 2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120045747/0001209191-20-045747-index.htm |
| 2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120045749/0001209191-20-045749-index.htm |
| 2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120045753/0001209191-20-045753-index.htm |
| 2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120045758/0001209191-20-045758-index.htm |
| 2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120045763/0001209191-20-045763-index.htm |
| 2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120045767/0001209191-20-045767-index.htm |
| 2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120045771/0001209191-20-045771-index.htm |
| 2020-10-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120053998/0001209191-20-053998-index.htm |
| 2020-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/914475/000120919120056981/0001209191-20-056981-index.htm |
| 2019-02-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/914475/000127417319000005/0001274173-19-000005-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/914475/000127417320000039/0001274173-20-000039-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/914475/000156223020000039/0001562230-20-000039-index.htm |
| 2019-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000156459019001996/0001564590-19-001996-index.htm |
| 2019-02-08 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/914475/000156459019002328/0001564590-19-002328-index.htm |
| 2019-03-14 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/914475/000156459019007831/0001564590-19-007831-index.htm |
| 2019-04-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000156459019013735/0001564590-19-013735-index.htm |
| 2019-04-29 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/914475/000156459019013745/0001564590-19-013745-index.htm |
| 2019-07-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000156459019026585/0001564590-19-026585-index.htm |
| 2019-07-29 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/914475/000156459019026602/0001564590-19-026602-index.htm |
| 2019-09-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000156459019034520/0001564590-19-034520-index.htm |
| 2019-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000156459019039789/0001564590-19-039789-index.htm |
| 2019-11-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/914475/000156459019039803/0001564590-19-039803-index.htm |
| 2019-11-05 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/914475/000156459019039948/0001564590-19-039948-index.htm |
| 2019-12-11 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/914475/000156459019045741/0001564590-19-045741-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000156459020000868/0001564590-20-000868-index.htm |
| 2020-02-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000156459020003267/0001564590-20-003267-index.htm |
| 2020-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000156459020003494/0001564590-20-003494-index.htm |
| 2020-02-07 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/914475/000156459020003773/0001564590-20-003773-index.htm |
| 2020-04-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000156459020016098/0001564590-20-016098-index.htm |
| 2020-04-09 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/914475/000156459020016115/0001564590-20-016115-index.htm |
| 2020-04-09 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/914475/000156459020016118/0001564590-20-016118-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000156459020021928/0001564590-20-021928-index.htm |
| 2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/914475/000156459020021952/0001564590-20-021952-index.htm |
| 2020-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000156459020026550/0001564590-20-026550-index.htm |
| 2020-06-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/914475/000156459020029427/0001564590-20-029427-index.htm |
| 2019-03-19 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/914475/999999999719001371/9999999997-19-001371-index.htm |
| 2019-09-27 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/914475/999999999719007139/9999999997-19-007139-index.htm |
Neurocrine Biosciences, Inc (NBIX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neurocrine Biosciences, Inc (NBIX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 126%Institutional Ownership: 9938%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-05-07 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 8,682.00 | 105.44 | 915,454.39 | 104,741.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120028392/0001209191-20-028392-index.htm |
| 2020-05-18 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 10,000.00 | 119.98 | 1,199,800.00 | 104,741.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120031028/0001209191-20-031028-index.htm |
| 2020-05-19 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 10,000.00 | 125.98 | 1,259,800.00 | 104,741.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120031028/0001209191-20-031028-index.htm |
| 2019-07-30 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 10,000.00 | 94.31 | 943,118.00 | 108,408.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119043916/0001209191-19-043916-index.htm |
| 2019-11-01 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 10,188.00 | 100.34 | 1,022,297.54 | 108,408.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119055228/0001209191-19-055228-index.htm |
| 2019-11-18 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 5,000.00 | 115.98 | 579,900.00 | 108,408.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119057272/0001209191-19-057272-index.htm |
| 2020-02-05 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 1,013.00 | 103.15 | 104,489.03 | 109,320.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007691/0001209191-20-007691-index.htm |
| 2020-02-05 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 605.00 | 103.15 | 62,405.33 | 109,865.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007691/0001209191-20-007691-index.htm |
| 2020-02-06 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 803.00 | 101.44 | 81,456.16 | 110,587.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007691/0001209191-20-007691-index.htm |
| 2020-02-07 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 1,218.00 | 103.31 | 125,832.55 | 111,682.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120008498/0001209191-20-008498-index.htm |
| 2019-11-18 | Dimitri E. Grigoriadis | Chief Research Officer | Buy | 5,000.00 | 35.99 | 179,950.00 | 113,408.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119057272/0001209191-19-057272-index.htm |
| 2020-04-24 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 1,934.00 | 99.41 | 192,258.17 | 113,423.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120026069/0001209191-20-026069-index.htm |
| 2020-08-05 | EIRY ROBERTS | Chief Medical Officer | Sell | 2,257.00 | 118.84 | 268,225.27 | 11,446.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120045771/0001209191-20-045771-index.htm |
| 2020-05-18 | Dimitri E. Grigoriadis | Chief Research Officer | Buy | 10,000.00 | 35.99 | 359,900.00 | 114,741.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120031028/0001209191-20-031028-index.htm |
| 2020-05-19 | Dimitri E. Grigoriadis | Chief Research Officer | Buy | 10,000.00 | 35.99 | 359,900.00 | 114,741.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120031028/0001209191-20-031028-index.htm |
| 2020-04-15 | ERIC BENEVICH | Chief Commercial Officer | Sell | 8,632.00 | 94.65 | 817,017.94 | 11,603.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120025028/0001209191-20-025028-index.htm |
| 2019-02-04 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 1,375.00 | 88.12 | 121,166.51 | 117,066.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007851/0001209191-19-007851-index.htm |
| 2019-02-05 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 669.00 | 88.17 | 58,983.52 | 118,322.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007851/0001209191-19-007851-index.htm |
| 2019-05-13 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 1,657.00 | 75.44 | 125,007.23 | 118,408.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119030173/0001209191-19-030173-index.htm |
| 2019-07-30 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 50,000.00 | 92.65 | 4,632,320.00 | 118,408.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119043916/0001209191-19-043916-index.htm |
| 2019-11-01 | Dimitri E. Grigoriadis | Chief Research Officer | Buy | 10,188.00 | 32.99 | 336,102.12 | 118,596.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119055228/0001209191-19-055228-index.htm |
| 2019-02-05 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 401.00 | 88.17 | 35,354.85 | 119,071.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007851/0001209191-19-007851-index.htm |
| 2019-02-06 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 531.00 | 84.03 | 44,621.58 | 120,065.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119008638/0001209191-19-008638-index.htm |
| 2020-04-24 | ERIC BENEVICH | Chief Commercial Officer | Sell | 1,934.00 | 99.45 | 192,337.85 | 13,344.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120026063/0001209191-20-026063-index.htm |
| 2019-02-04 | Haig P. Bozigian | Chief Development Officer | Sell | 1,375.00 | 88.10 | 121,139.01 | 137,372.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007847/0001209191-19-007847-index.htm |
| 2019-02-05 | Haig P. Bozigian | Chief Development Officer | Sell | 465.00 | 88.06 | 40,949.34 | 138,244.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007847/0001209191-19-007847-index.htm |
| 2019-02-05 | Haig P. Bozigian | Chief Development Officer | Sell | 885.00 | 88.18 | 78,037.09 | 139,909.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007847/0001209191-19-007847-index.htm |
| 2019-02-06 | Haig P. Bozigian | Chief Development Officer | Sell | 920.00 | 83.54 | 76,859.38 | 141,639.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119008629/0001209191-19-008629-index.htm |
| 2019-05-13 | Haig P. Bozigian | Chief Development Officer | Sell | 34,547.00 | 75.51 | 2,608,813.25 | 141,976.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119030172/0001209191-19-030172-index.htm |
| 2019-05-16 | Haig P. Bozigian | Chief Development Officer | Sell | 22,439.00 | 80.13 | 1,797,992.19 | 141,976.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119031531/0001209191-19-031531-index.htm |
| 2019-05-22 | Haig P. Bozigian | Chief Development Officer | Sell | 1,300.00 | 80.03 | 104,037.05 | 141,976.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119032451/0001209191-19-032451-index.htm |
| 2019-05-24 | Haig P. Bozigian | Chief Development Officer | Sell | 17,486.00 | 80.03 | 1,399,434.31 | 141,976.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119033260/0001209191-19-033260-index.htm |
| 2019-05-31 | Haig P. Bozigian | Chief Development Officer | Sell | 19,297.00 | 85.02 | 1,640,580.77 | 141,976.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119034056/0001209191-19-034056-index.htm |
| 2019-06-03 | Haig P. Bozigian | Chief Development Officer | Sell | 3,435.00 | 85.51 | 293,718.61 | 141,976.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119034913/0001209191-19-034913-index.htm |
| 2019-06-13 | Haig P. Bozigian | Chief Development Officer | Sell | 15,836.00 | 82.56 | 1,307,356.82 | 141,976.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119037472/0001209191-19-037472-index.htm |
| 2019-06-13 | Haig P. Bozigian | Chief Development Officer | Sell | 1,432.00 | 83.29 | 119,270.99 | 141,976.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119037472/0001209191-19-037472-index.htm |
| 2019-06-18 | Haig P. Bozigian | Chief Development Officer | Sell | 2,100.00 | 87.82 | 184,416.54 | 141,976.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119038288/0001209191-19-038288-index.htm |
| 2019-07-10 | Haig P. Bozigian | Chief Development Officer | Sell | 7,120.00 | 87.63 | 623,957.64 | 141,976.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119041925/0001209191-19-041925-index.htm |
| 2019-07-11 | Haig P. Bozigian | Chief Development Officer | Sell | 100.00 | 87.59 | 8,759.00 | 141,976.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119041925/0001209191-19-041925-index.htm |
| 2019-07-15 | Haig P. Bozigian | Chief Development Officer | Sell | 30,680.00 | 87.50 | 2,684,506.14 | 141,976.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119042522/0001209191-19-042522-index.htm |
| 2019-07-30 | Haig P. Bozigian | Chief Development Officer | Sell | 18,756.00 | 91.74 | 1,720,630.43 | 141,976.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119043914/0001209191-19-043914-index.htm |
| 2019-07-30 | Haig P. Bozigian | Chief Development Officer | Sell | 25,600.00 | 93.52 | 2,394,227.20 | 141,976.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119043914/0001209191-19-043914-index.htm |
| 2019-07-11 | Haig P. Bozigian | Chief Development Officer | Buy | 100.00 | 32.99 | 3,299.00 | 142,076.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119041925/0001209191-19-041925-index.htm |
| 2019-05-16 | Haig P. Bozigian | Chief Development Officer | Buy | 731.00 | 19.59 | 14,320.29 | 142,707.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119031531/0001209191-19-031531-index.htm |
| 2019-05-22 | Haig P. Bozigian | Chief Development Officer | Buy | 1,300.00 | 19.59 | 25,467.00 | 143,276.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119032451/0001209191-19-032451-index.htm |
| 2020-02-05 | Haig P. Bozigian | Chief Development Officer | Sell | 1,342.00 | 103.00 | 138,223.05 | 143,292.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007674/0001209191-20-007674-index.htm |
| 2019-06-13 | Haig P. Bozigian | Chief Development Officer | Buy | 1,432.00 | 32.99 | 47,241.68 | 143,408.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119037472/0001209191-19-037472-index.htm |
| 2020-02-05 | Haig P. Bozigian | Chief Development Officer | Sell | 704.00 | 103.06 | 72,555.86 | 143,925.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007674/0001209191-20-007674-index.htm |
| 2019-06-18 | Haig P. Bozigian | Chief Development Officer | Buy | 2,100.00 | 32.99 | 69,279.00 | 144,076.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119038288/0001209191-19-038288-index.htm |
| 2020-06-23 | EIRY ROBERTS | Chief Medical Officer | Buy | 5,000.00 | 77.81 | 389,050.00 | 14,416.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120038896/0001209191-20-038896-index.htm |
| 2020-02-06 | Haig P. Bozigian | Chief Development Officer | Sell | 1,395.00 | 101.56 | 141,670.06 | 145,180.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007674/0001209191-20-007674-index.htm |
| 2019-06-03 | Haig P. Bozigian | Chief Development Officer | Buy | 3,435.00 | 19.59 | 67,291.65 | 145,411.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119034913/0001209191-19-034913-index.htm |
| 2020-02-07 | Haig P. Bozigian | Chief Development Officer | Sell | 1,623.00 | 103.33 | 167,701.67 | 146,641.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120008484/0001209191-20-008484-index.htm |
| 2020-04-24 | Haig P. Bozigian | Chief Development Officer | Sell | 1,934.00 | 99.46 | 192,351.19 | 148,633.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120026064/0001209191-20-026064-index.htm |
| 2020-05-12 | Haig P. Bozigian | Chief Development Officer | Sell | 9,094.00 | 114.94 | 1,045,303.46 | 148,633.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120029401/0001209191-20-029401-index.htm |
| 2019-07-10 | Haig P. Bozigian | Chief Development Officer | Buy | 7,120.00 | 32.99 | 234,888.80 | 149,096.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119041925/0001209191-19-041925-index.htm |
| 2019-07-15 | ERIC BENEVICH | Chief Commercial Officer | Sell | 5,835.00 | 87.44 | 510,201.31 | 14,910.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119042520/0001209191-19-042520-index.htm |
| 2020-08-05 | Haig P. Bozigian | Chief Development Officer | Sell | 2,257.00 | 118.89 | 268,324.35 | 150,663.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120045742/0001209191-20-045742-index.htm |
| 2019-05-16 | Haig P. Bozigian | Chief Development Officer | Buy | 9,121.00 | 5.76 | 52,536.96 | 151,097.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119031531/0001209191-19-031531-index.htm |
| 2020-08-05 | ERIC BENEVICH | Chief Commercial Officer | Sell | 2,257.00 | 118.85 | 268,254.16 | 15,374.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120045725/0001209191-20-045725-index.htm |
| 2020-11-02 | ERIC BENEVICH | Chief Commercial Officer | Sell | 20,595.00 | 96.53 | 1,987,971.51 | 15,374.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120056981/0001209191-20-056981-index.htm |
| 2020-05-12 | Haig P. Bozigian | Chief Development Officer | Buy | 9,094.00 | 35.99 | 327,293.06 | 157,727.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120029401/0001209191-20-029401-index.htm |
| 2019-06-13 | Haig P. Bozigian | Chief Development Officer | Buy | 15,836.00 | 19.59 | 310,227.24 | 157,812.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119037472/0001209191-19-037472-index.htm |
| 2019-05-24 | Haig P. Bozigian | Chief Development Officer | Buy | 17,486.00 | 19.59 | 342,550.74 | 159,462.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119033260/0001209191-19-033260-index.htm |
| 2019-07-30 | Haig P. Bozigian | Chief Development Officer | Buy | 18,756.00 | 32.99 | 618,760.44 | 160,732.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119043914/0001209191-19-043914-index.htm |
| 2019-05-31 | Haig P. Bozigian | Chief Development Officer | Buy | 19,297.00 | 19.59 | 378,028.23 | 161,273.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119034056/0001209191-19-034056-index.htm |
| 2020-02-05 | ERIC BENEVICH | Chief Commercial Officer | Sell | 1,145.00 | 103.11 | 118,063.35 | 16,279.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007671/0001209191-20-007671-index.htm |
| 2019-05-16 | Haig P. Bozigian | Chief Development Officer | Buy | 22,439.00 | 35.99 | 807,579.61 | 164,415.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119031531/0001209191-19-031531-index.htm |
| 2020-05-12 | Haig P. Bozigian | Chief Development Officer | Buy | 15,833.00 | 81.49 | 1,290,231.17 | 164,466.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120029401/0001209191-20-029401-index.htm |
| 2019-02-05 | Malcolm Lloyd-Smith | Chief Regulatory Officer | Sell | 669.00 | 88.16 | 58,975.83 | 16,574.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007854/0001209191-19-007854-index.htm |
| 2020-05-12 | Haig P. Bozigian | Chief Development Officer | Buy | 18,057.00 | 81.05 | 1,463,519.85 | 166,690.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120029401/0001209191-20-029401-index.htm |
| 2020-05-12 | Haig P. Bozigian | Chief Development Officer | Buy | 18,571.00 | 43.24 | 803,010.04 | 167,204.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120029401/0001209191-20-029401-index.htm |
| 2019-07-30 | Haig P. Bozigian | Chief Development Officer | Buy | 25,600.00 | 43.24 | 1,106,944.00 | 167,576.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119043914/0001209191-19-043914-index.htm |
| 2019-07-30 | Dimitri E. Grigoriadis | Chief Research Officer | Buy | 50,000.00 | 32.99 | 1,649,500.00 | 168,408.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119043916/0001209191-19-043916-index.htm |
| 2020-02-05 | ERIC BENEVICH | Chief Commercial Officer | Sell | 809.00 | 102.90 | 83,247.88 | 17,007.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007671/0001209191-20-007671-index.htm |
| 2019-07-15 | Haig P. Bozigian | Chief Development Officer | Buy | 30,680.00 | 32.99 | 1,012,133.20 | 172,656.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119042522/0001209191-19-042522-index.htm |
| 2019-02-05 | Darin Lippoldt | Chief Legal Officer | Sell | 755.00 | 88.08 | 66,501.08 | 17,482.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007852/0001209191-19-007852-index.htm |
| 2019-02-05 | Malcolm Lloyd-Smith | Chief Regulatory Officer | Sell | 603.00 | 88.13 | 53,142.75 | 17,508.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007854/0001209191-19-007854-index.htm |
| 2019-02-05 | ERIC BENEVICH | Chief Commercial Officer | Sell | 602.00 | 88.08 | 53,025.67 | 17,595.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007846/0001209191-19-007846-index.htm |
| 2019-05-16 | Haig P. Bozigian | Chief Development Officer | Buy | 34,376.00 | 8.65 | 297,352.40 | 176,352.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119031531/0001209191-19-031531-index.htm |
| 2019-05-13 | Haig P. Bozigian | Chief Development Officer | Buy | 34,547.00 | 8.66 | 299,177.02 | 176,523.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119030172/0001209191-19-030172-index.htm |
| 2019-02-05 | Darin Lippoldt | Chief Legal Officer | Sell | 470.00 | 88.11 | 41,409.49 | 18,162.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007852/0001209191-19-007852-index.htm |
| 2020-02-06 | ERIC BENEVICH | Chief Commercial Officer | Sell | 1,395.00 | 101.48 | 141,560.83 | 18,262.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007671/0001209191-20-007671-index.htm |
| 2019-02-05 | ERIC BENEVICH | Chief Commercial Officer | Sell | 755.00 | 87.95 | 66,401.04 | 19,015.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007846/0001209191-19-007846-index.htm |
| 2019-02-06 | Malcolm Lloyd-Smith | Chief Regulatory Officer | Sell | 920.00 | 83.58 | 76,893.78 | 19,238.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119008643/0001209191-19-008643-index.htm |
| 2018-12-03 | MATT ABERNETHY | Chief Financial Officer | Sell | 1,178.00 | 90.00 | 106,019.65 | 1,947.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919118061372/0001209191-18-061372-index.htm |
| 2019-10-14 | Malcolm Lloyd-Smith | Chief Regulatory Officer | Sell | 9,956.00 | 90.85 | 904,486.67 | 19,613.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119053286/0001209191-19-053286-index.htm |
| 2019-02-06 | Darin Lippoldt | Chief Legal Officer | Sell | 791.00 | 83.52 | 66,063.37 | 19,646.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119008639/0001209191-19-008639-index.htm |
| 2019-07-30 | Darin Lippoldt | Chief Legal Officer | Sell | 15,831.00 | 92.13 | 1,458,568.60 | 19,961.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119043918/0001209191-19-043918-index.htm |
| 2019-08-23 | Darin Lippoldt | Chief Legal Officer | Sell | 1,664.00 | 100.09 | 166,554.92 | 19,961.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119047571/0001209191-19-047571-index.htm |
| 2019-08-27 | Darin Lippoldt | Chief Legal Officer | Sell | 1,600.00 | 100.00 | 160,000.00 | 19,961.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119047571/0001209191-19-047571-index.htm |
| 2020-02-07 | ERIC BENEVICH | Chief Commercial Officer | Sell | 2,030.00 | 103.32 | 209,747.31 | 20,087.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120008481/0001209191-20-008481-index.htm |
| 2019-09-03 | Darin Lippoldt | Chief Legal Officer | Sell | 6,736.00 | 100.00 | 673,600.00 | 20,103.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119048482/0001209191-19-048482-index.htm |
| 2019-11-08 | Darin Lippoldt | Chief Legal Officer | Sell | 6,625.00 | 110.00 | 728,750.00 | 20,103.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119056381/0001209191-19-056381-index.htm |
| 2019-11-08 | Darin Lippoldt | Chief Legal Officer | Sell | 3,375.00 | 110.02 | 371,307.38 | 20,103.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119056381/0001209191-19-056381-index.htm |
| 2020-02-05 | Malcolm Lloyd-Smith | Chief Regulatory Officer | Sell | 1,083.00 | 103.03 | 111,586.36 | 20,455.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007686/0001209191-20-007686-index.htm |
| 2019-02-06 | ERIC BENEVICH | Chief Commercial Officer | Sell | 920.00 | 83.57 | 76,883.02 | 20,745.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119008628/0001209191-19-008628-index.htm |
| 2020-05-07 | MATT ABERNETHY | Chief Financial Officer | Buy | 15,000.00 | 73.60 | 1,104,000.00 | 20,953.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120028394/0001209191-20-028394-index.htm |
| 2020-02-05 | Malcolm Lloyd-Smith | Chief Regulatory Officer | Sell | 865.00 | 103.06 | 89,146.47 | 21,127.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007686/0001209191-20-007686-index.htm |
| 2020-02-05 | Darin Lippoldt | Chief Legal Officer | Sell | 1,145.00 | 102.88 | 117,800.46 | 21,133.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007683/0001209191-20-007683-index.htm |
| 2019-08-27 | Darin Lippoldt | Chief Legal Officer | Buy | 1,600.00 | 32.99 | 52,784.00 | 21,561.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119047571/0001209191-19-047571-index.htm |
| 2019-08-23 | Darin Lippoldt | Chief Legal Officer | Buy | 1,664.00 | 32.99 | 54,895.36 | 21,625.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119047571/0001209191-19-047571-index.htm |
| 2020-02-05 | Darin Lippoldt | Chief Legal Officer | Sell | 605.00 | 103.15 | 62,406.54 | 21,678.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007683/0001209191-20-007683-index.htm |
| 2020-02-06 | Malcolm Lloyd-Smith | Chief Regulatory Officer | Sell | 1,490.00 | 101.52 | 151,257.95 | 22,287.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007686/0001209191-20-007686-index.htm |
| 2019-11-08 | GARY A LYONS | Director | Sell | 5,000.00 | 110.00 | 550,000.00 | 225,697.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119056385/0001209191-19-056385-index.htm |
| 2020-02-06 | Darin Lippoldt | Chief Legal Officer | Sell | 1,198.00 | 101.47 | 121,555.67 | 22,755.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007683/0001209191-20-007683-index.htm |
| 2019-11-01 | GARY A LYONS | Director | Sell | 5,000.00 | 100.22 | 501,103.50 | 230,697.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119055235/0001209191-19-055235-index.htm |
| 2020-02-07 | Malcolm Lloyd-Smith | Chief Regulatory Officer | Sell | 1,015.00 | 103.28 | 104,826.56 | 23,200.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120008513/0001209191-20-008513-index.htm |
| 2020-02-10 | Malcolm Lloyd-Smith | Chief Regulatory Officer | Sell | 13,042.00 | 104.56 | 1,363,710.65 | 23,200.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120008513/0001209191-20-008513-index.htm |
| 2019-11-08 | Darin Lippoldt | Chief Legal Officer | Buy | 3,375.00 | 32.99 | 111,341.25 | 23,478.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119056381/0001209191-19-056381-index.htm |
| 2019-07-30 | GARY A LYONS | Director | Sell | 10,000.00 | 92.07 | 920,686.00 | 235,697.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119043920/0001209191-19-043920-index.htm |
| 2020-02-07 | Darin Lippoldt | Chief Legal Officer | Sell | 1,522.00 | 103.32 | 157,247.10 | 24,124.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120008503/0001209191-20-008503-index.htm |
| 2020-04-24 | Malcolm Lloyd-Smith | Chief Regulatory Officer | Sell | 1,934.00 | 99.45 | 192,329.14 | 24,941.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120026071/0001209191-20-026071-index.htm |
| 2020-04-24 | Darin Lippoldt | Chief Legal Officer | Sell | 1,934.00 | 99.49 | 192,415.98 | 26,021.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120026070/0001209191-20-026070-index.htm |
| 2020-05-18 | Darin Lippoldt | Chief Legal Officer | Sell | 5,000.00 | 120.00 | 600,000.00 | 26,021.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120031033/0001209191-20-031033-index.htm |
| 2020-06-23 | Darin Lippoldt | Chief Legal Officer | Sell | 5,000.00 | 130.00 | 650,000.00 | 26,021.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120038890/0001209191-20-038890-index.htm |
| 2020-07-09 | Darin Lippoldt | Chief Legal Officer | Sell | 1,657.00 | 136.02 | 225,385.80 | 26,021.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120042167/0001209191-20-042167-index.htm |
| 2019-11-08 | Darin Lippoldt | Chief Legal Officer | Buy | 6,625.00 | 32.99 | 218,558.75 | 26,728.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119056381/0001209191-19-056381-index.htm |
| 2019-09-03 | Darin Lippoldt | Chief Legal Officer | Buy | 6,736.00 | 32.99 | 222,220.64 | 26,839.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119048482/0001209191-19-048482-index.htm |
| 2020-08-05 | Malcolm Lloyd-Smith | Chief Regulatory Officer | Sell | 2,257.00 | 118.86 | 268,277.40 | 26,971.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120045767/0001209191-20-045767-index.htm |
| 2020-07-09 | Darin Lippoldt | Chief Legal Officer | Buy | 1,657.00 | 35.99 | 59,635.43 | 27,678.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120042167/0001209191-20-042167-index.htm |
| 2020-08-05 | Darin Lippoldt | Chief Legal Officer | Sell | 2,257.00 | 118.87 | 268,297.26 | 28,051.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120045763/0001209191-20-045763-index.htm |
| 2018-11-26 | RICHARD F POPS | Director | Sell | 4,124.00 | 91.37 | 376,789.67 | 29,512.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919118060053/0001209191-18-060053-index.htm |
| 2019-10-14 | Malcolm Lloyd-Smith | Chief Regulatory Officer | Buy | 9,956.00 | 15.45 | 153,820.20 | 29,569.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119053286/0001209191-19-053286-index.htm |
| 2020-04-28 | STEPHEN A SHERWIN | Director | Sell | 17,687.00 | 99.39 | 1,757,965.76 | 29,861.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120026306/0001209191-20-026306-index.htm |
| 2020-05-18 | Darin Lippoldt | Chief Legal Officer | Buy | 5,000.00 | 32.99 | 164,950.00 | 31,021.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120031033/0001209191-20-031033-index.htm |
| 2020-06-23 | Darin Lippoldt | Chief Legal Officer | Buy | 5,000.00 | 32.99 | 164,950.00 | 31,021.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120038890/0001209191-20-038890-index.htm |
| 2019-01-08 | EIRY ROBERTS | Chief Medical Officer | Sell | 1,857.00 | 84.09 | 156,158.66 | 3,143.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119003276/0001209191-19-003276-index.htm |
| 2019-10-02 | Julie Cooke | Chief Human Resources Officer | Sell | 987.00 | 88.56 | 87,408.72 | 3,276.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119052596/0001209191-19-052596-index.htm |
| 2018-11-12 | RICHARD F POPS | Director | Sell | 4,123.00 | 103.30 | 425,892.71 | 33,636.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919118058377/0001209191-18-058377-index.htm |
| 2019-07-30 | Darin Lippoldt | Chief Legal Officer | Buy | 15,831.00 | 18.15 | 287,332.65 | 35,792.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119043918/0001209191-19-043918-index.htm |
| 2020-11-02 | ERIC BENEVICH | Chief Commercial Officer | Buy | 20,595.00 | 35.99 | 741,214.05 | 35,969.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120056981/0001209191-20-056981-index.htm |
| 2020-02-10 | Malcolm Lloyd-Smith | Chief Regulatory Officer | Buy | 13,042.00 | 32.99 | 430,255.58 | 36,242.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120008513/0001209191-20-008513-index.htm |
| 2020-02-05 | Julie Cooke | Chief Human Resources Officer | Sell | 605.00 | 103.17 | 62,417.31 | 3,821.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007676/0001209191-20-007676-index.htm |
| 2019-12-02 | MATT ABERNETHY | Chief Financial Officer | Sell | 1,645.00 | 116.33 | 191,360.38 | 3,876.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119059146/0001209191-19-059146-index.htm |
| 2020-02-10 | Malcolm Lloyd-Smith | Chief Regulatory Officer | Buy | 15,927.00 | 81.49 | 1,297,891.23 | 39,127.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120008513/0001209191-20-008513-index.htm |
| 2019-02-04 | KEVIN CHARLES GORMAN | Chief Executive Officer | Sell | 3,125.00 | 88.10 | 275,320.94 | 408,082.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007850/0001209191-19-007850-index.htm |
| 2019-02-05 | KEVIN CHARLES GORMAN | Chief Executive Officer | Sell | 2,497.00 | 88.12 | 220,041.88 | 410,185.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007850/0001209191-19-007850-index.htm |
| 2019-02-05 | KEVIN CHARLES GORMAN | Chief Executive Officer | Sell | 1,992.00 | 88.28 | 175,853.36 | 413,943.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007850/0001209191-19-007850-index.htm |
| 2019-02-06 | KEVIN CHARLES GORMAN | Chief Executive Officer | Sell | 4,096.00 | 84.23 | 344,985.60 | 417,597.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119008635/0001209191-19-008635-index.htm |
| 2019-08-06 | KEVIN CHARLES GORMAN | Chief Executive Officer | Sell | 50,911.00 | 95.15 | 4,844,380.20 | 417,597.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119045228/0001209191-19-045228-index.htm |
| 2019-08-07 | KEVIN CHARLES GORMAN | Chief Executive Officer | Sell | 2,759.00 | 95.12 | 262,440.49 | 417,597.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119045228/0001209191-19-045228-index.htm |
| 2019-08-08 | KEVIN CHARLES GORMAN | Chief Executive Officer | Sell | 26,330.00 | 95.64 | 2,518,153.81 | 417,597.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119045228/0001209191-19-045228-index.htm |
| 2019-03-12 | NEUROCRINE BIOSCIENCES INC | 10% Share Holder | Buy | 4,179,728.00 | 11.96 | 49,999,996.20 | 4,179,728.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119019459/0001209191-19-019459-index.htm |
| 2019-08-07 | KEVIN CHARLES GORMAN | Chief Executive Officer | Buy | 2,759.00 | 8.66 | 23,892.94 | 420,356.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119045228/0001209191-19-045228-index.htm |
| 2019-08-09 | KEVIN CHARLES GORMAN | Chief Executive Officer | Buy | 3,031.00 | 32.99 | 99,992.69 | 420,628.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119045763/0001209191-19-045763-index.htm |
| 2020-02-05 | KEVIN CHARLES GORMAN | Chief Executive Officer | Sell | 3,027.00 | 103.08 | 312,032.85 | 423,351.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007681/0001209191-20-007681-index.htm |
| 2020-02-05 | KEVIN CHARLES GORMAN | Chief Executive Officer | Sell | 2,422.00 | 103.09 | 249,692.94 | 425,529.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007681/0001209191-20-007681-index.htm |
| 2020-02-06 | KEVIN CHARLES GORMAN | Chief Executive Officer | Sell | 4,343.00 | 101.56 | 441,067.70 | 429,436.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007681/0001209191-20-007681-index.htm |
| 2020-02-07 | KEVIN CHARLES GORMAN | Chief Executive Officer | Sell | 3,248.00 | 103.35 | 335,696.07 | 432,357.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120008494/0001209191-20-008494-index.htm |
| 2020-04-24 | KEVIN CHARLES GORMAN | Chief Executive Officer | Sell | 2,906.00 | 99.45 | 289,015.65 | 434,971.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120026068/0001209191-20-026068-index.htm |
| 2020-08-05 | KEVIN CHARLES GORMAN | Chief Executive Officer | Sell | 3,390.00 | 118.91 | 403,101.17 | 438,021.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120045753/0001209191-20-045753-index.htm |
| 2019-08-08 | KEVIN CHARLES GORMAN | Chief Executive Officer | Buy | 26,330.00 | 8.66 | 228,017.80 | 443,927.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119045228/0001209191-19-045228-index.htm |
| 2020-02-07 | Julie Cooke | Chief Human Resources Officer | Sell | 913.00 | 103.26 | 94,276.20 | 4,643.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120008487/0001209191-20-008487-index.htm |
| 2019-08-06 | KEVIN CHARLES GORMAN | Chief Executive Officer | Buy | 50,911.00 | 8.66 | 440,889.26 | 468,508.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119045228/0001209191-19-045228-index.htm |
| 2020-02-07 | MATT ABERNETHY | Chief Financial Officer | Sell | 2,030.00 | 103.35 | 209,806.59 | 5,701.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120008478/0001209191-20-008478-index.htm |
| 2020-04-28 | MATT ABERNETHY | Chief Financial Officer | Sell | 1,741.00 | 102.49 | 178,435.09 | 5,953.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120026302/0001209191-20-026302-index.htm |
| 2020-05-07 | MATT ABERNETHY | Chief Financial Officer | Sell | 15,000.00 | 110.21 | 1,653,133.50 | 5,953.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120028394/0001209191-20-028394-index.htm |
| 2020-01-08 | EIRY ROBERTS | Chief Medical Officer | Sell | 2,632.00 | 111.11 | 292,444.94 | 5,991.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120003043/0001209191-20-003043-index.htm |
| 2020-04-24 | Julie Cooke | Chief Human Resources Officer | Sell | 1,934.00 | 99.46 | 192,363.57 | 6,631.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120026065/0001209191-20-026065-index.htm |
| 2020-05-19 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 32,749.00 | 126.73 | 4,150,133.40 | 71,992.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120031028/0001209191-20-031028-index.htm |
| 2020-02-07 | EIRY ROBERTS | Chief Medical Officer | Sell | 1,623.00 | 103.31 | 167,675.38 | 7,452.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120008518/0001209191-20-008518-index.htm |
| 2020-06-11 | Dimitri E. Grigoriadis | Chief Research Officer | Buy | 2,710.00 | 32.99 | 89,402.90 | 74,702.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120036698/0001209191-20-036698-index.htm |
| 2020-06-11 | Dimitri E. Grigoriadis | Chief Research Officer | Buy | 1,812.00 | 35.99 | 65,213.88 | 76,514.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120036698/0001209191-20-036698-index.htm |
| 2020-04-24 | MATT ABERNETHY | Chief Financial Officer | Sell | 1,934.00 | 99.52 | 192,466.85 | 7,694.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120026062/0001209191-20-026062-index.htm |
| 2020-06-11 | Dimitri E. Grigoriadis | Chief Research Officer | Buy | 1,049.00 | 43.24 | 45,358.76 | 77,563.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120036698/0001209191-20-036698-index.htm |
| 2020-08-05 | Dimitri E. Grigoriadis | Chief Research Officer | Sell | 2,257.00 | 118.83 | 268,199.76 | 79,593.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120045758/0001209191-20-045758-index.htm |
| 2020-08-05 | MATT ABERNETHY | Chief Financial Officer | Sell | 2,257.00 | 118.90 | 268,355.95 | 7,983.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120045716/0001209191-20-045716-index.htm |
| 2019-02-04 | Kyle Gano | Chief Business Development Off | Sell | 1,375.00 | 88.14 | 121,186.31 | 80,117.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007849/0001209191-19-007849-index.htm |
| 2019-02-05 | Kyle Gano | Chief Business Development Off | Sell | 465.00 | 88.05 | 40,943.20 | 80,989.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007849/0001209191-19-007849-index.htm |
| 2019-02-05 | Kyle Gano | Chief Business Development Off | Sell | 1,300.00 | 88.14 | 114,575.89 | 83,439.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007849/0001209191-19-007849-index.htm |
| 2019-02-05 | Kyle Gano | Chief Business Development Off | Sell | 669.00 | 88.14 | 58,962.52 | 84,695.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119007849/0001209191-19-007849-index.htm |
| 2019-02-06 | Kyle Gano | Chief Business Development Off | Sell | 762.00 | 83.56 | 63,672.64 | 85,833.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919119008630/0001209191-19-008630-index.htm |
| 2020-08-05 | Julie Cooke | Chief Human Resources Officer | Sell | 2,257.00 | 118.91 | 268,382.80 | 8,661.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120045747/0001209191-20-045747-index.htm |
| 2020-02-05 | Kyle Gano | Chief Business Development Off | Sell | 1,013.00 | 103.01 | 104,346.29 | 87,204.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007695/0001209191-20-007695-index.htm |
| 2020-02-05 | Kyle Gano | Chief Business Development Off | Sell | 703.00 | 103.03 | 72,433.39 | 87,838.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007695/0001209191-20-007695-index.htm |
| 2020-02-05 | Kyle Gano | Chief Business Development Off | Sell | 1,974.00 | 103.08 | 203,482.29 | 89,614.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007695/0001209191-20-007695-index.htm |
| 2020-02-06 | Kyle Gano | Chief Business Development Off | Sell | 1,000.00 | 101.41 | 101,413.00 | 90,514.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120007695/0001209191-20-007695-index.htm |
| 2020-02-07 | Kyle Gano | Chief Business Development Off | Sell | 1,623.00 | 103.33 | 167,710.27 | 91,975.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120008491/0001209191-20-008491-index.htm |
| 2020-04-24 | Kyle Gano | Chief Business Development Off | Sell | 1,934.00 | 99.47 | 192,376.72 | 93,967.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120026066/0001209191-20-026066-index.htm |
| 2020-04-24 | EIRY ROBERTS | Chief Medical Officer | Sell | 1,934.00 | 99.47 | 192,376.33 | 9,416.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120026072/0001209191-20-026072-index.htm |
| 2020-06-23 | EIRY ROBERTS | Chief Medical Officer | Sell | 5,000.00 | 130.00 | 650,000.00 | 9,416.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120038896/0001209191-20-038896-index.htm |
| 2020-10-02 | Julie Cooke | Chief Human Resources Officer | Sell | 987.00 | 95.26 | 94,021.62 | 9,549.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120053998/0001209191-20-053998-index.htm |
| 2020-08-05 | Kyle Gano | Chief Business Development Off | Sell | 2,257.00 | 118.87 | 268,285.53 | 95,997.00 | https://www.sec.gov/Archives/edgar/data/914475/000120919120045749/0001209191-20-045749-index.htm |